Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Gamma Globulin Observations and Outcomes Database for Specific Home Infusion Evidence, Patient Care And Research Data in Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)
Sponsor: BriovaRx Infusion Services
Terminated
Sponsor Decision
Other terminated trials from BriovaRx Infusion Services
More terminations from BriovaRx Infusion Services
Listed as NCT01883921, this observational or N/A phase trial focuses on Primary Immune Deficiency Disorder and remains terminated or withdrawn. Sponsored by BriovaRx Infusion Services, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Sep 2019 — Jan 2021 [monthly]
Terminated
Status: Recruiting → Terminated
-
May 2019 — Sep 2019 [monthly]
Recruiting
▶ Show 4 earlier versions
-
Feb 2019 — May 2019 [monthly]
Recruiting
-
Jun 2018 — Feb 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jun 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BriovaRx Infusion Services
For direct contact, visit the study record on ClinicalTrials.gov .